Natan Kraitman in Sarasota, Florida

Medical School: Sorry, his university is not listed
Graduation Year: 2013
The Primary Medical Specialty for Natan Kraitman is listed as: Infectious Disease
Approximate Years of Experience: 11
PAC (PECOS ID)#: 9638483845
NPI #: 1568806222
NPI Created On: 04/24/2013
NPI Last Updated Listed as: 04/20/2021
Primary Taxonomy Code: 207RI0200X
License Number:
ME139743
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• Humana
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Russian.

Services and Procedures include:

1. Insertion of needle into vein for collection of blood sample
2. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
3. Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
4. New patient office or other outpatient visit, typically 60 minutes
5. Established patient office or other outpatient, visit typically 25 minutes
6. Established patient office or other outpatient, visit typically 40 minutes
7. Established patient office or other outpatient, visit typically 40 minutes
8. Initial hospital inpatient care, typically 70 minutes per day
9. Subsequent hospital inpatient care, typically 25 minutes per day
10. Subsequent hospital inpatient care, typically 35 minutes per day
11. Initial nursing facility visit, typically 45 minutes per day
12. Subsequent nursing facility visit, typically 25 minutes per day
13. Subsequent nursing facility visit, typically 35 minutes per day
14. Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge
15. Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge
16. Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem
17. Injection, ceftriaxone sodium, per 250 mg
18. Injection, dalbavancin, 5 mg
19. Injection, daptomycin, 1 mg
20. Injection, ertapenem sodium, 500 mg